A way out of the Brexit morass?
09 May 2019 – 14:15 | No Comment

Brexit-bound Britain will participate in this month’s European Parliament (EP) election, unless UK prime minister, Theresa May, and opposition leader, Jeremy Corbyn, manage to push the thrice-rejected EU withdrawal agreement through the House of Commons …

Read the full story »
Health

Energy & Environment

Circular Economy

Climate Change

Security

Home » Archive by Tags

Articles tagged with: prostate cancer

A radical vision to beat prostate cancer in Europe
14 Jul 2017 – 09:30
A radical vision to beat prostate cancer in Europe

An increasing trend in the incidence of prostate cancer (PCa) has been observed in almost all European countries over the last few decades. There are no population-based, organised programmes for PCa in Europe as existing …

Latest twists in PCa diagnosis and treatment
14 Jul 2017 – 09:25
Latest twists in PCa diagnosis and treatment

Prof Dr Hein Van Poppel, Adjunct Secretary General – Education, European Association for Urology, provides an overview of the latest in the fast moving field of prostate cancer diagnosis and management
Population based PSA screening has …

Integrating patient preference into treatment decisions prove crucial
14 Jul 2017 – 09:25
Integrating patient preference into treatment decisions prove crucial

Director of the European Cancer Patient Coalition, Dr Lydia Makaroff, writes that patients should be partners in their own treatments, as well as empowered to offer insights and practical recommendations to improve policy
The rates of …

Professional groups call for action to lower the risk and mortality rate of prostate cancer
14 Jul 2017 – 09:20
Professional groups call for action to lower the risk and mortality rate of prostate cancer

Implementing prostate cancer awareness campaigns and corresponding survivorship plans, at both European and national levels, are key elements in effective healthcare strategies, but these moves have to be underpinned by a dynamic research environment and …

European Commission’s action on health priorities
31 Mar 2016 – 13:14
European Commission’s action on health priorities

In an exclusive interview with Government Gazette, Vytenis Andriukaitis, European Commissioner for Health and Food Safety, discusses the EU action on cancer, diabetes and healthcare technology
The incidence of prostate cancer and diabetes has significantly increased …

Towards a paradigm shift in diagnosis and management
31 Mar 2016 – 10:00
Towards a paradigm shift in diagnosis and management

Over the past years, there has been a fundamental change in the way prostate cancer has been diagnosed and treated, with patients having a greater variety of options to choose from. Prof Ronald Van Velthoven, …

Reducing mortality rates tops MAC’s latest agenda
31 Mar 2016 – 10:00
Reducing mortality rates tops MAC’s latest agenda

The MEPs Against Cancer (MAC) group strives to reduce cancer incidence by promoting prevention, reducing mortality through equitable access to high-quality care and ensuring good quality of life for cancer patients. MEP Nessa Childers, Vice …

The five faces of prostate cancer
31 Mar 2016 – 10:00
The five faces of prostate cancer

Prostate cancer can no longer be treated as one disease. Dr. Alastair Lamb, Clinical Lecturer in Urology, Cambridge Biomedical Campus, UK, outlines some recent work identifying genetic subtypes of prostate cancer and how this could …

Active surveillance – a great alternative to curative therapies
30 Mar 2016 – 17:29
Active surveillance – a great alternative to curative therapies

The ‘active surveillance’ protocol has become an alternative to curative therapy for prostate cancer that is unlikely to be biologically or clinically significant. However, Dr Riccardo Valdagni, Director, Radiation Oncology, European School of Oncology says …

Innovative therapies must be made accessible to all
30 Mar 2016 – 17:27
Innovative therapies must be made accessible to all

Access pathways must foster innovation to address unmet needs, align evidence requirements as treatment options move earlier in the disease course, and remove barriers to access for patients. Jane Griffiths, Group Chairman, Janssen Europe, Middle …